lightbulb In short
There is currently 1 ongoing clinical trial for testicular leiomyosarcoma, a rare type of soft tissue sarcoma. This trial is investigating combination therapy for patients with advanced or metastatic disease who did not respond to previous treatments. The study is being conducted in Germany and compares standard chemotherapy with an experimental combination approach.
Summary
Currently, there is one clinical trial available for patients with testicular leiomyosarcoma, which is a type of soft tissue sarcoma. This trial is being conducted in Germany and offers an opportunity for patients whose cancer has spread or has not responded to standard first-line treatments. The study investigates whether combining an experimental drug with standard chemotherapy can improve outcomes compared to chemotherapy alone. Patients interested in participating must meet specific criteria, including having tumors that test positive for CD13 and a life expectancy of at least 3 months. The trial is expected to continue until March 2029.